Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Bozoki

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
JAMA Neurology|May 26, 2018
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive ImpairmentDavid A Wolk, Carl Sadowsky, Beth Safirstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2017
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's diseaseStephen Salloway, Jose E Gamez, Upinder Singh, et al.
JAMA Neurology|January 27, 2015
Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque densityCraig Curtis, Jose E Gamez, Upinder Singh, et al.
JAMA Neurology|November 1, 2024
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group RecommendationBruno Dubois, Nicolas Villain, Lon Schneider, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementiaJuan-Camilo Vargas-Gonzalez, Nico Dimal, Kasey Cortez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsCeline N Sakran, Juan-Camilo Vargas-González, Nico Paulo Dimal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsJuan-Camilo Vargas-González, Hessah A Alotibi, Kasey Cortez, et al.
Brain Communications|January 16, 2025
Brain aging rejuvenation factors in adults with genetic and sporadic neurodegenerative diseaseKaitlin B Casaletto, Rowan Saloner, John Kornak, et al.
Journal of Neurology|April 30, 2026
Factors influencing accelerated progression in behavioral variant frontotemporal dementiaMolly Split, Zachary J Kunicki, Daliah Ross, et al.
JAMA Network Open|April 1, 2024
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar DegenerationAdam M Staffaroni, Annie L Clark, Jack C Taylor, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
JAMA Neurology|May 26, 2018
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive ImpairmentDavid A Wolk, Carl Sadowsky, Beth Safirstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2017
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's diseaseStephen Salloway, Jose E Gamez, Upinder Singh, et al.
JAMA Neurology|January 27, 2015
Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque densityCraig Curtis, Jose E Gamez, Upinder Singh, et al.
JAMA Neurology|November 1, 2024
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group RecommendationBruno Dubois, Nicolas Villain, Lon Schneider, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2024
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementiaJuan-Camilo Vargas-Gonzalez, Nico Dimal, Kasey Cortez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsCeline N Sakran, Juan-Camilo Vargas-González, Nico Paulo Dimal, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsJuan-Camilo Vargas-González, Hessah A Alotibi, Kasey Cortez, et al.
Brain Communications|January 16, 2025
Brain aging rejuvenation factors in adults with genetic and sporadic neurodegenerative diseaseKaitlin B Casaletto, Rowan Saloner, John Kornak, et al.
Journal of Neurology|April 30, 2026
Factors influencing accelerated progression in behavioral variant frontotemporal dementiaMolly Split, Zachary J Kunicki, Daliah Ross, et al.
JAMA Network Open|April 1, 2024
Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar DegenerationAdam M Staffaroni, Annie L Clark, Jack C Taylor, et al.
Pageof 4